日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

利索卡巴吉内马拉鲁塞输注后2周以上发生细胞因子释放综合征(CRS)或免疫复合物相关神经病变(ICANS)的情况很少见:来自临床试验和真实世界的数据

Hunter, Bradley D; Lunning, Matthew; Shadman, Mazyar; Ahmed, Sairah; Abramson, Jeremy S; Perales, Miguel-Angel; Ahmed, Nausheen; Mirza, Abu-Sayeef; Isufi, Iris; Frigault, Matthew J; Crombie, Jennifer L; Miklos, David B; Vasconcelos, Alberto; Crotta, Alessandro; Bernasconi, David; Roy, Debasmita; Bleickardt, Eric; Pasquini, Marcelo C; Kamdar, Manali

Risk of Cancer in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-analysis

化脓性汗腺炎患者的癌症风险:系统评价和荟萃分析

Isufi, Daniel; Jensen, Mikkel Bak; Loft, Nikolai; Andersen, Rune Kjærsgaard

Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial

在参与 CARTITUDE-4 试验的多发性骨髓瘤患者中验证多发性骨髓瘤症状和影响问卷 (MySIm-Q)

Mina, Roberto; Mylin, Anne K; Yokoyama, Hisayuki; Magen, Hila; Alsdorf, Winfried; Shune, Leyla; Isufi, Iris; Harrison, Simon J; Shah, Urvi A; De Champlain, André; Katz, Eva G; Gries, Katharine S; Schecter, Jordan M; Lendvai, Nikoletta; Slaughter, Ana; Lonardi, Carolina; Deraedt, William; Costa Filho, Octavio; Patel, Nitin; Florendo, Erika; Ho, Kai Fai; Karlin, Lionel; Weisel, Katja

Empowering Women Through Pharmaceutical Education: A New Approach to Premenstrual Syndrome

通过药学教育赋能女性:治疗经前综合症的新方法

Celia, Piquer-Martinez; Manuel, Gomez-Guzman; Adriana, Gonzalez-Salgado; Isabel, Valverde-Merino Maria; Francisco Javier, Ferreira-Alfaya; Blete, Isufi; Victoria, Garcia-Cardenas; Francisco, Rivas-Garcia; Jose, Zarzuelo Maria

Anesthetic and Transfusion Management in Placenta Accreta Spectrum: Lessons From a Resource-Limited Setting and Mini-Review

胎盘植入谱系疾病的麻醉和输血管理:来自资源匮乏环境的经验教训及简要回顾

Soxhuku Isufi, Alma; Hyska, Genci; Dallaku, Kastriot; Shpata, Vjollca; Frasheri Prendushi, Xhensila; Shahini, Albana; Abdyli, Asead; Lilaj, Krenar; Sula, Hektor; Domi, Rudin; Sada, Fatos

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma

纳武利尤单抗联合异环磷酰胺、卡铂和依托泊苷是治疗高危复发/难治性霍奇金淋巴瘤的一线挽救治疗方案,疗效显著。

Mei, Matthew; Palmer, Joycelynne; Lee, Hun Ju; Isufi, Iris; Chen, Robert; Tsai, Ni-Chun; Armenian, Saro; Godfrey, James; Song, Joo Y; Baird, John H; Thiruvengadam, Swetha; Samara, Yazeed; Flores, Jessica; Peters, Lacolle; Rosen, Steven; Kwak, Larry; Forman, Stephen J; Herrera, Alex F

2D Metalorganic Ferromagnets

二维金属有机铁磁体

Isufi Neziri, Egzona; Hensky, Céline; Le, Hien Quy; Radillo Ochoa, Diego; Cebrat, Aleksandra; Parschau, Manfred; Ernst, Karl-Heinz; Wäckerlin, Christian

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

一项多中心 I/II 期临床试验,研究来那度胺联合剂量调整的 EPOCH-R 方案治疗 MYC 相关弥漫性大 B 细胞淋巴瘤的疗效。

Cahill, Kirk; Godfrey, James; Nabhan, Chadi; Kline, Justin; Riedell, Peter A; Cohen, Kenneth S; Narula, Sunil; Karrison, Theodore G; Robertson, Jessica; Karmali, Reem; Venugopal, Parameswaran; Kim, Seo-Hyun; Rapoport, Aaron P; Lee, Seung Tae; Law, Jennie; Fishkin, Paul A S; Isufi, Iris; Velasco, Mario; Kaminer, Lynne; Smith, Sonali M

MU-Glioma Post: A comprehensive dataset of automated MR multi-sequence segmentation and clinical features

MU-胶质瘤后:一个包含自动磁共振多序列分割和临床特征的综合数据集

Mahmoud, Esmat; Gass, Jaime; Dhemesh, Yaseen; Greaser, Josh; Pogorzelski, Karolina; Isufi, Edvin; Garrett, Filip; Thacker, Jonathan; Tahon, Nourel Hoda; Sinclair, Jason; Layfield, Lester; Altes, Talissa; Nada, Ayman

The Association Between Genetics and Response to Treatment with Biologics in Patients with Psoriasis

遗传因素与银屑病患者生物制剂治疗反应之间的关联

Loft, Nikolai; Altintas, Sule; Al-Sofi, Rownaq; Isufi, Daniel; Zachariae, Claus; Kaur-Knudsen, Diljit; Nielsen, Claus Henrik; Skov, Lone